News Related to Chronic Myeloid Leukemia

Related coverage linked through entity extraction aliases.

Novartis sets new long-term social impact and sustainability targets

May 05, 2026

Novartis introduced new long-term social impact and sustainability targets covering access, global health, emissions, waste and water. The plan includes a 2030 access goal and net-zero across the value chain by 2040.

Ascentage Pharma to present ASCO clinical data and AACR preclinical studies in 2026

Apr 22, 2026

Ascentage Pharma said six clinical abstracts were selected for ASCO 2026 and four preclinical studies will be presented at AACR 2026. The presentations feature olverembatinib and other pipeline candidates.